Fufeng Group Valuation

Is 546 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 546 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 546 (HK$4.65) is trading below our estimate of fair value (HK$7.49)

Significantly Below Fair Value: 546 is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 546?

Key metric: As 546 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 546. This is calculated by dividing 546's market cap by their current earnings.
What is 546's PE Ratio?
PE Ratio4.1x
EarningsCN¥2.65b
Market CapCN¥10.85b

Price to Earnings Ratio vs Peers

How does 546's PE Ratio compare to its peers?

The above table shows the PE ratio for 546 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average18.4x
1907 China Risun Group
48.2x43.9%HK$13.4b
189 Dongyue Group
15x42.6%HK$11.9b
3983 China BlueChemical
6.3x4.3%HK$9.1b
1866 China XLX Fertiliser
4.1x11.6%HK$6.0b
546 Fufeng Group
4.1x8.8%HK$11.7b

Price-To-Earnings vs Peers: 546 is good value based on its Price-To-Earnings Ratio (4.1x) compared to the peer average (18.6x).


Price to Earnings Ratio vs Industry

How does 546's PE Ratio compare vs other companies in the HK Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
546 4.1xIndustry Avg. 9.1xNo. of Companies8PE0816243240+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 546 is good value based on its Price-To-Earnings Ratio (4.1x) compared to the Hong Kong Chemicals industry average (9.3x).


Price to Earnings Ratio vs Fair Ratio

What is 546's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

546 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio4.1x
Fair PE Ratio8.4x

Price-To-Earnings vs Fair Ratio: 546 is good value based on its Price-To-Earnings Ratio (4.1x) compared to the estimated Fair Price-To-Earnings Ratio (8.4x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 546 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentHK$4.62
HK$5.90
+27.6%
10.4%HK$6.51HK$5.28n/a2
Nov ’25HK$4.47
HK$5.90
+31.9%
10.4%HK$6.51HK$5.28n/a2
Oct ’25HK$4.82
HK$5.90
+22.3%
10.4%HK$6.51HK$5.28n/a2
Sep ’25HK$4.39
HK$5.96
+35.7%
10.9%HK$6.61HK$5.31n/a2
Aug ’25HK$4.62
HK$6.15
+33.2%
5.8%HK$6.51HK$5.79n/a2
Jul ’25HK$5.31
HK$6.15
+15.9%
5.8%HK$6.51HK$5.79n/a2
Jun ’25HK$6.10
HK$6.15
+0.8%
5.8%HK$6.51HK$5.79n/a2
Apr ’25HK$5.07
HK$6.16
+21.5%
5.9%HK$6.52HK$5.80n/a2
Mar ’25HK$4.78
HK$6.15
+28.8%
5.8%HK$6.51HK$5.80n/a2
Feb ’25HK$4.30
HK$6.15
+43.1%
5.8%HK$6.51HK$5.80n/a2
Jan ’25HK$4.33
HK$6.15
+42.1%
5.8%HK$6.51HK$5.80n/a2
Dec ’24HK$4.20
HK$6.15
+46.5%
5.8%HK$6.51HK$5.80n/a2
Nov ’24HK$4.08
HK$6.15
+50.9%
5.8%HK$6.51HK$5.80HK$4.472
Oct ’24HK$4.41
HK$6.15
+39.6%
5.8%HK$6.51HK$5.80HK$4.822
Sep ’24HK$4.17
HK$6.15
+47.6%
5.8%HK$6.51HK$5.80HK$4.392
Aug ’24HK$4.18
HK$6.93
+65.8%
16.9%HK$8.10HK$5.76HK$4.622
Jul ’24HK$3.96
HK$6.93
+75.0%
16.9%HK$8.10HK$5.76HK$5.312
Jun ’24HK$4.25
HK$6.93
+63.0%
16.9%HK$8.10HK$5.76HK$6.102
May ’24HK$4.75
HK$6.93
+45.9%
16.9%HK$8.10HK$5.76HK$5.732
Mar ’24HK$5.23
HK$6.78
+29.7%
14.5%HK$7.77HK$5.80HK$4.782
Feb ’24HK$5.55
HK$6.78
+22.2%
14.5%HK$7.77HK$5.80HK$4.302
Jan ’24HK$4.75
HK$6.78
+42.8%
14.5%HK$7.77HK$5.80HK$4.332
Dec ’23HK$5.08
HK$6.78
+33.6%
14.5%HK$7.77HK$5.80HK$4.202
Nov ’23HK$4.15
HK$6.78
+63.5%
14.5%HK$7.77HK$5.80HK$4.082

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.


Discover undervalued companies